Shandong Weigao Group Medical Polymer Company Limited Stock price

Equities

1066

CNE100000171

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 03:08:18 2024-03-05 am EST 5-day change 1st Jan Change
4.88 HKD -3.37% Intraday chart for Shandong Weigao Group Medical Polymer Company Limited -6.51% -35.87%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site

Financials

Sales 2023 * 13.53B 1.88B 14.7B Sales 2024 * 15.31B 2.13B 16.64B Capitalization 21.24B 2.95B 23.08B
Net income 2023 * 2.03B 282M 2.21B Net income 2024 * 2.68B 372M 2.91B EV / Sales 2023 * 1.12 x
Net cash position 2023 * 6.03B 837M 6.55B Net cash position 2024 * 7.09B 985M 7.71B EV / Sales 2024 * 0.92 x
P/E ratio 2023 *
10.4 x
P/E ratio 2024 *
7.84 x
Employees 12,333
Yield 2023 *
2.92%
Yield 2024 *
3.13%
Free-Float 52.98%
More Fundamentals * Assessed data
Dynamic Chart
Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023 CI
Shandong Weigao Group Medical Polymer Company Limited Announces the Resignation of Ni Has Tendered as Executive Director, Effective from 31 December 2023 CI
Crown International Chairman Resigns; Successor Named MT
Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023 CI
Shandong Weigao to Allot Over 97 Million Shares to Staffers MT
Weigao Group Medical Polymer Slashes Dividend as H1 Profit Declines 16% MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023 CI
Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shandong Weigao Flags Up to 19% Fall in H1 Profit MT
Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023 CI
Nomura Adjusts Shandong Weigao's Price Target to HK$13.26 From HK14.79, Keeps at Buy MT
Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2022, Payable on or Before 14 July 2023 CI
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$14.79 From HK$15.90, Keeps at Buy MT
Weigao Group Logs 14% Rise in 2022 Profit MT
Shandong Weigao Group Medical Polymer Company Limited Proposes Ordinary Final Dividend for the Year Ended December 31, 2022, Payable on 14 July 2023 CI
More news
1 day-3.37%
1 week-6.51%
Current month-4.13%
1 month+0.21%
3 months-27.92%
6 months-35.96%
Current year-35.87%
More quotes
1 week
4.85
Extreme 4.85
5.25
1 month
4.48
Extreme 4.48
5.29
Current year
4.48
Extreme 4.48
7.70
1 year
4.48
Extreme 4.48
14.18
3 years
4.48
Extreme 4.48
20.65
5 years
4.48
Extreme 4.48
22.70
10 years
4.11
Extreme 4.11
22.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 03-07-31
Director of Finance/CFO 46 01-06-30
Chairman 50 05-06-30
Members of the board TitleAgeSince
Chairman 50 05-06-30
Director/Board Member 58 22-09-27
Director/Board Member 52 22-06-05
More insiders
Date Price Change Volume
24-03-05 4.88 -3.37% 5 298 128
24-03-04 5.05 -0.20% 6,635,600
24-03-01 5.06 -0.59% 5,240,368
24-02-29 5.09 +1.39% 11,841,610
24-02-28 5.02 -3.83% 9,733,200

Delayed Quote Hong Kong S.E., March 05, 2024 at 03:08 am EST

More quotes
Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
4.646 CNY
Average target price
10.48 CNY
Spread / Average Target
+125.60%
Consensus
  1. Stock
  2. Equities
  3. Stock Shandong Weigao Group Medical Polymer Company Limited - Hong Kong S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW